Jiangsu Hengrui Medicine
600276.SS
#503
Rank
C$58.53 B
Marketcap
$9.18
Share price
0.39%
Change (1 day)
6.64%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total debt

Total debt on the balance sheet as of September 2024 : C$17.88 Million

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total debt is C$17.88 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Jiangsu Hengrui Medicine - Total debt on balance sheet (from 2000 to 2024)

Total debt by year

Year Total debt Change
2022-12-31C$0.26 B782.43%
2021-12-31C$30.31 M
2015-12-31C$2.14 M14.55%
2014-12-31C$1.87 M-46.73%
2013-12-31C$3.51 M120.57%
2012-12-31C$1.59 M-50.73%
2011-12-31C$3.23 M7.06%
2010-12-31C$3.02 M96.27%
2009-12-31C$1.54 M
2007-12-31C$8.2 M14.62%
2006-12-31C$7.15 M3.36%
2005-12-31C$6.92 M-51.85%
2004-12-31C$14.38 M-75.88%
2003-12-31C$59.63 M21.85%
2002-12-31C$48.94 M0.95%
2001-12-31C$48.48 M46.62%
2000-12-31C$33.06 M-6.22%
1999-12-31C$35.26 M35.28%
1998-12-31C$26.06 M18.62%
1997-12-31C$21.97 M